PerkinElmer Wins Leadership Award for Contribution to Healthcare in India
Download PDF Read more
Digital microscopes – without eyepieces – are being used more frequently for quality inspection because of their ease of use, enhanced capabilities in 2D and 3D analysis, and reliable and repeatable results. This webinar from Leica will clear up common misconceptions about digital magnification, resolution and megapixels, and explain why optics in digital microscopes are... Read more
FRANKLIN LAKES, N.J., April 23, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Tom Polen, 43, as president of BD, effective immediately. In his new role, Mr. Polen will oversee all of BD’s operating segments – the Medical and Life Sciences segments, as... Read more
VIENNA, April 21, 2017 /PRNewswire/ — At the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Bruker tomorrow will introduce important new clinical microbiology assays and consumables kits to further enhance the MALDI Biotyper® (MBT) platform. Bruker will also introduce novel, real-time PCR assays and kits for fast molecular testing of invasive aspergillosis... Read more
CAMBRIDGE, UK and SAN DIEGO, USA – April 20, 2017 – Congenica and Edico Genome today announced the companies have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inherited diseases which otherwise takes months or years.... Read more
Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more
Thermo Fisher Scientific Inc. today announced that results from the multi-center Procalcitonin MOnitoring SEpsis (MOSES) Study have been published in the May 2017 print issue of Critical Care Medicine. Researchers from the study, titled “Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study,” investigated the use of... Read more
Thermo Fisher Scientific has signed an agreement with the Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland, to establish the leading institution as the first partner in the Next Generation Sequencing Companion Dx Center of Excellence Program, a new initiative designed to develop and refine Thermo Fisher’s NGS-based research assays from its... Read more
BREA, California – April 20, 2017 Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis Beckman Coulter Diagnostics announced a partnership with Diazyme Laboratories that allows customers access to a procalcitonin (PCT) assay, an important marker for the detection and management of bacterial infections and sepsis. The high-quality, fully... Read more
Menu to include Procalcitonin (PCT)Beckman Coulter Sample Press Release Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis BREA, CALIF. — (April 20, 2017) — Beckman Coulter Diagnostics announced a partnership with Diazyme Laboratories that allows customers access to a procalcitonin (PCT) assay, an important marker for the detection... Read more